PRENW
Prenetics Holding Company LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-11.04
Beta
0.15
52W High
$0.07
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-63.10%
Forward P/E
—
PEG Ratio
—
About Prenetics Holding Company Limited
Prenetics Holding Company Limited is a pioneering global healthcare technology firm dedicated to enhancing health outcomes through innovative genetic testing and digital health solutions. By offering a comprehensive suite of genetic screening and diagnostics, the company utilizes advanced technologies and data analytics to drive personalized medicine and deliver actionable health insights. As the market for precision health solutions continues to grow, Prenetics is strategically expanding its product offerings to seize emerging opportunities in a rapidly evolving, data-driven healthcare environment.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.94M |
| EBITDA | $-32.97M |
| Operating Margin | -33.30% |
| Return on Equity | -31.80% |
| Return on Assets | -11.00% |
| Revenue/Share (TTM) | $6.57 |
| Book Value | $10.89 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | 0 |
| Float | $11.92M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
130.46%
HV 20-Day
118.18%
HV 30-Day
100.50%
HV 60-Day
81.95%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/5/2026